The people have spoken.
And they want serialization solutions that can provide end-to-end traceability and ROI.
In January, Acsis and Pharmaceutical Commerce surveyed manufacturers to capture serialization priorities, challenges and the benefits of going “beyond” Drug Supply Chain Security Act (DSCSA) compliance.
What did we find out? That manufacturers’ expectations for serialization go “beyond compliance” and “beyond the edge” to include value-based and revenue-generating payback, such as more precise chargebacks and less grey market leakage.
While immediate compliance may be the initial driver for serialization, it’s clear that it shouldn’t be the only driving force behind a solution choice and deployment. Forty-two percent of respondents expect that serialization efforts will improve both return and recall management and 32% cite brand protection as a key anticipated benefit.
And while many manufacturers are on their way to deploying serialization at the packaging line, 43% are concerned about the warehouse serialization challenges of technical integration and 53% about the readiness of their outsourced partners.
At Acsis, we understand that there’s more to serialization than compliance. That’s why our Edge solutions not only address DSCSA compliance mandates, but also deliver better operational traceability and seamless integration with ERP, EPCIS and warehouse management systems. Streamlined serialization, data collection and management from the production line through the entire supply network means that you will realize a ROI and those expected benefits – through a foundation for tighter returns and recall processes.
The shift from a “compliance now” attitude to a “think twice, implement once” approach is necessary to build a truly traceable, serialized warehouse. And it will mitigate the risk of adding even more disintegrated systems, additional manual processes and rework of current initiatives.
Interested in hearing more about this approach and the implications of the survey results? Along with AmerisourceBergen and Excellis Healthcare, we will explore these topics and more in a Pharmaceutical Commerce webinar on Wednesday, February 10 at 2 p.m. EST. Register here for this free webinar.